Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that some experience infants shortly after birth. While withdrawal syndromes have been described after in utero exposure to several substances, opioids remain the most common exposure leading to NAS. Opioids are a broad class of drugs, which include legal prescriptions like oxycodone, and illicit drugs like heroin. Infants with NAS display a myriad of clinical signs, including breathing problems, feeding difficulties and rarely seizures. Recently, NAS became more common in communities in the US as use of prescription opioids grew rapidly. The complexity of the opioid epidemic itself requires a multi-disciplinary approach focused on improving clinical care, research and outreach to the public.



Click Below on Your Area of the Country

13.7 per 1000 Births (12.5 - 14.5)16.2 per 1000 Births (12.4 - 18.9)6.8 per 1000 Births (5.9 - 7.6)6.9 per 1000 Births (6.0 - 7.8)3.0 per 1000 Births (2.7 - 3.4)3.4 per 1000 Births (3.0 - 3.8)6.9 per 1000 Births (6.3 - 7.4)2.6 per 1000 Births (2.3 - 2.9)5.1 per 1000 Births (4.6 - 5.5)

Source: Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing Incidence and Geographic Distribution of Neonatal Abstinence Syndrome: United States 2009-2012. Journal of Perinatology.

Data presented are from analysis of the Kids' Inpatient Sample 2012